Walleye Capital’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$633K Buy
8,731
+6,330
+264% +$456K ﹤0.01% 3883
2026
Q2
$170K Sell
2,401
-130,006
-98% -$7.02M ﹤0.01% 3597
2026
Q1
$6.92M Sell
132,407
-8,061
-6% -$484K 0.03% 599
2025
Q4
$8.26M Sell
140,468
-302,706
-68% -$18.4M 0.03% 784
2025
Q3
$24.7M Buy
+443,174
New +$23.7M 0.09% 193
2025
Q2
– Sell
-57,315
Closed -$2.88M – 5027
2025
Q1
$3.36M Buy
+57,315
New +$3.88M 0.02% 1060
2024
Q4
– Sell
-1,685
Closed -$135K – 5546
2024
Q3
$135K Sell
1,685
-30,813
-95% -$2.32M ﹤0.01% 4253
2024
Q2
$2.33M Buy
32,498
+30,711
+1,719% +$2.26M ﹤0.01% 1961
2024
Q1
$126K Buy
+1,787
New +$128K ﹤0.01% 4266
2023
Q2
– Sell
-2,372
Closed -$191K – 4872
2023
Q1
$176K Sell
2,372
-659
-22% -$50.8K ﹤0.01% 2562
2022
Q4
$251K Buy
+3,031
New +$241K ﹤0.01% 1902
2022
Q2
– Sell
-5,376
Closed -$582K – 2716
2022
Q1
$582K Buy
+5,376
New +$555K 0.02% 930

Other funds holding TECH

Walleye Capital's TECH Position: Q3 2026 in Review

Walleye Capital increased its Bio-Techne (TECH) stake by 264% in Q3 2026, buying an estimated $456K and bringing the position to 8,731 shares worth $633K. The position accounts for ﹤0.01% of the portfolio, ranked #3883.

Walleye Capital first reported a position in TECH in Q1 2022 and has held it in 12 quarters since. The position peaked at $24.7M in Q3 2025. 581 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Walleye Capital held 8,731 shares of Bio-Techne worth $633K as of Q3 2026.
  • Walleye Capital bought 6,330 Bio-Techne shares in Q3 2026, an estimated $456K.
  • Bio-Techne made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #3883 holding.
  • Walleye Capital first reported a position in Bio-Techne in Q1 2022 and has held it in 12 quarters since.
  • Walleye Capital's Bio-Techne position peaked at $24.7M in Q3 2025.
  • 581 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.